International Society for the Study of Women's Sexual Health

Resources

Role of Biotechnology and Pharmaceutical Companies in Developing Novel Therapies for Female Sexual Dysfunction

Details
  Published: Tuesday, 16 May 2017
Female sexual disorders have historically been treated with multiple non-medical and off-label medical therapies by a limited number of experienced clinicians. Yet, most therapies have insufficient clinical evidence to support their safety and efficacy. Thus, the development of safe and effective therapies for the treatment of sexual disorders in women is critical to improving the overall management of these conditions, and increasing access to care. The International Society for the Study of Women’s Sexual Health (ISSWSH) supports the role of biotechnology and pharmaceutical companies, and other investigators developing novel therapies for female sexual dysfunction. ISSWSH rejects a “one size fits all” approach to treating female sexual dysfunction due to the multiplicity of biopsychosocial factors that impact sexual health. The concept of personalized medicine, and the availability of multiple therapeutic options are critical in this field.

Save the Date

ISSWSH Fall Course 2019
November 14-16, 2019   0 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH Annual Meeting 2020
March 5-8, 2020   112 days left
Renaissance Orlando at Seaworld, Orlando, FL, USA

ISSWSH Sexual Pain Course 2020
April 17-18, 2020 112 days left
Georgetown University Medical Center, Medical and Dental Building, Washington, DC, USA

ISSWSH Annual Meeting 2021
March 4-7, 2021   476 days left
Renaissance Dallas Hotel, Dallas, TX, USA

Latest Tweets

@StephFaubionMD and Management of Genitourinary Syndrome of Menopause in Female Cancer Patients: A Focus on Vaginal… https://t.co/ydvLaADZ2V ISSWSH
About 19 hours ago
Retrospective chart review shows that patients with vulvodynia do NOT have higher rates of infertility treatment co… https://t.co/Ri5nVIzNL9 ISSWSH
About 2 days ago
One of the biggest warnings when using Addyi for female HSDD is hypotension and syncope with alcohol consumption.… https://t.co/UNxsJIzI1J ISSWSH
About 3 days ago

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Follow us on Twitter!